Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Transcriptional Profiling of Xenogeneic Transplants: Examining Human Pluripotent Stem Cell-Derived Grafts in the Rodent Brain.

Bye CR, Penna V, de Luzy IR, Gantner CW, Hunt CPJ, Thompson LH, Parish CL.

Stem Cell Reports. 2019 Nov 12;13(5):877-890. doi: 10.1016/j.stemcr.2019.10.001. Epub 2019 Oct 31.

2.

Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.

de Luzy IR, Niclis JC, Gantner CW, Kauhausen JA, Hunt CPJ, Ermine C, Pouton CW, Thompson LH, Parish CL.

J Neurosci. 2019 Nov 27;39(48):9521-9531. doi: 10.1523/JNEUROSCI.1160-19.2019. Epub 2019 Oct 22.

PMID:
31641054
3.

A PITX3-EGFP Reporter Line Reveals Connectivity of Dopamine and Non-dopamine Neuronal Subtypes in Grafts Generated from Human Embryonic Stem Cells.

Niclis JC, Gantner CW, Hunt CPJ, Kauhausen JA, Durnall JC, Haynes JM, Pouton CW, Parish CL, Thompson LH.

Stem Cell Reports. 2017 Sep 12;9(3):868-882. doi: 10.1016/j.stemcr.2017.08.002. Epub 2017 Aug 31.

4.

Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.

Niclis JC, Gantner CW, Alsanie WF, McDougall SJ, Bye CR, Elefanty AG, Stanley EG, Haynes JM, Pouton CW, Thompson LH, Parish CL.

Stem Cells Transl Med. 2017 Mar;6(3):937-948. doi: 10.5966/sctm.2016-0073. Epub 2016 Oct 14.

Supplemental Content

Loading ...
Support Center